RE: 1509/monkeymoo13 Dec 2020 13:50
Troajan
I appreciate your comments
RMS is a risk and like most shares the degree of risk of your chosen shares varies.
Each investor will do their own research and then decide whether or not to buy into a share.
I understand as far as i can the fundamentals at rms and I get your point.
Take the face mask away from rms and you are left with
P2f - anticipated sales of nano fertilizer and treatment to help stop citrus greening
Cloudveil - Cyber and physical security
Gyrometric - Digital rotating shaft monitoring - typically now aimed and wind turbines trials with Tarmac offshore turbines to start in q1 2021.
The revenue will start coming in in January 2021 when the sales of face masks start to take off. It is anticipated that the partnership with Volz will help introduce new products using the antiviral material
Rms is not a one trick pony and with the new Director on board at p2f, this part of the company will be moving in the right direction.
I would like to see new directors appointed at rms as, as far as i am concerned,both TB and PR have no interest in moving the company forward.
At the moment I am happy to keep holding rms . If we have another spike then I am likely to offload some as the current directors of rms do make my nervous.
Heaven for me at this moment in time would be for 3m to pull some change out of its pocket and buy out p2f from rms, the shareholders given a special dividend
January is likely to be a pivotal month for the company. news from
P2f - orders
Gyrometric - offshore trials of hardware/software
Time will tell
Alb